The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway

70Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

Abstract

Stimulator of interferon genes (STING) is critical for cytosolic DNA-triggered innate immunity. STING is modified by several types of polyubiquitin chains. Here, we report that the deubiquitinase CYLD sustains STING signaling by stabilizing the STING protein. CYLD deficiency promoted the K48-linked polyubiquitination and degradation of STING, attenuating the induction of IRF3-responsive genes after HSV-1 infection or the transfection of DNA ligands. Additionally, CYLD knockout mice were more susceptible to HSV-1 infection than their wild-type (WT) littermates. Mechanistically, STING translocated from the ER to the Golgi upon HSV-1 stimulation; CYLD partially accumulated with STING and interacted selectively with K48-linked polyubiquitin chains on STING, specifically removing the K48-linked polyubiquitin chains from STING and ultimately boosting the innate antiviral response. Our study reveals that CYLD is a novel checkpoint in the cGAS-STING signaling pathway and sheds new light on the dynamic regulation of STING activity by ubiquitination.

Cite

CITATION STYLE

APA

Zhang, L., Wei, N., Cui, Y., Hong, Z., Liu, X., Wang, Q., … Wang, C. (2018). The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway. PLoS Pathogens, 14(11). https://doi.org/10.1371/journal.ppat.1007435

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free